How can global business leaders deliver on ambitions of growth and reinvention?
Gil Carrara, U.S. Managing Partner and Healthcare & Life Sciences Regional Leader, discusses new strategic opportunities stemming from the health and wellness sector this year.
The biotech industry has expanded rapidly in the past decade, with investment in biotechnology and pharmaceutical firms pouring in from venture capitalists.
Going virtual – how COVID has accelerated a real shift in clinical trial methodology
Having risen to the COVID-19 challenge and reaped financial gains, firms could invest in R&D and grow their share in the global biotechnology market.
Having held a steady focus on personalised healthcare through its diagnostics unit, pharmaceutical giant Roche is digging deeper with data analytics.
Gil Carrara, Americas Leader of Boyden’s Healthcare & Life Sciences Practice, looks at how Microsoft and other tech firms are changing the healthcare landscape.